Literature DB >> 25278737

Substance Abuse and the HIV Situation in Malaysia.

Darshan Singh1, Marek C Chawarski2, Richard Schottenfeld2, Balasingam Vicknasingam1.   

Abstract

Heroin continues to be the main drug used in Malaysia, while amphetamine-type stimulants (ATS) have been recently identified as a growing problem. A cumulative total of 300,241 drug users were detected between 1988 and 2006. It is also estimated that Malaysia has 170,000 injecting drug users. HIV prevalence among drug users in the country ranges from 25% to 45%. Currently, there are approximately 380 general medical practice offices that offer agonist maintenance treatments for approximately 10,000 patients. There are 27,756 active patients in 333 general medical practice offices and government-run methadone maintenance treatment (MMT) centers. The Needle Syringe Exchange Program (NSEP) reached out to 34,244 injection drug users (IDUs) in 2011. In the last 2 years (2011 and 2012) the number of detected drug addicts decreased from 11,194 to 9015. The arrests made by the police related to opiate and cannabis use increased from 41,363 to 63,466 between the years 2008 and 2010, but decreased since 2010. An almost four-fold increase in the number of ATS and ketamine users was detected from 2006 (21,653 users) 2012 (76,812). Between 2004 and 2010, the yearly seizures for heroin ranged between 156 to 270 kg. However, in 2010 and 2011, heroin seizures showed a significant increase of 445kg and 410.02 kg, respectively. There has been a seizure of between 600 to 1000kg of syabu yearly from 2009 to 2012. Similar to heroin, increased seizures for Yaba have also been observed over the last 2 years. A significant increase has also been recorded for the seizures of ecstasy pills from 2011 (47,761 pills) to 2012 (634,573 pills). The cumulative number of reported HIV infections since 1986 is 94,841. In 2011, sexual activity superseded injection drug use as the main transmission factor for the epidemic. HIV in the country mainly involves males, as they constitute 90% of cumulative HIV cases and a majority of those individuals are IDUs. However, HIV infection trends are shifting from males to females. There are 37,306 people living with HIV (PLHIV) who are eligible for treatment, and 14,002 PLHIV were receiving antiretroviral treatment (ART) in 2011. The decreasing trend of heroin users who have been detected and arrested could be due to the introduction of medical treatments and harm reduction approaches for drug users, resulting in fewer drug users being arrested. However, we are unable to say with certainty why there has been an increase in heroin seizures in the country. There has been an increasing trend in both ATS users and seizures. A new trend of co-occurring opiate dependence and ATS underscores the need to develop and implement effective treatments for ATS, co-occurring opiate and ATS, and polysubstance abuse disorders. The low numbers of NSEP clients being tested for HIV underscores our caution in interpreting the decline of HIV infections among drug users and the importance of focusing on providing education, prevention, treatment, and outreach to those who are not in treatment.

Entities:  

Keywords:  HIV; amphetamine type stimulants (ATS); drug user; heroin; opiates

Year:  2013        PMID: 25278737      PMCID: PMC4179250          DOI: 10.1016/j.jfda.2013.09.033

Source DB:  PubMed          Journal:  J Food Drug Anal            Impact factor:   6.079


  8 in total

1.  Malaysia and harm reduction: the challenges and responses.

Authors:  Gary Reid; Adeeba Kamarulzaman; Sangeeta Kaur Sran
Journal:  Int J Drug Policy       Date:  2007-01-29

2.  The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.

Authors:  Suresh Narayanan; Balasingam Vicknasingam; Noorzurani Md Haris Robson
Journal:  Int J Drug Policy       Date:  2011-02-05

3.  The relative risk of HIV among IDUs not in treatment in Malaysia.

Authors:  Balasingam Vicknasingam; Suresh Narayanan; Visweswaran Navaratnam
Journal:  AIDS Care       Date:  2009-08

4.  Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia.

Authors:  Marek C Chawarski; Balasingam Vicknasingam; Mahmud Mazlan; Richard S Schottenfeld
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

Review 5.  Meth/amphetamine use and associated HIV: Implications for global policy and public health.

Authors:  Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard
Journal:  Int J Drug Policy       Date:  2010-02-01

6.  Amphetamine-group substances and HIV.

Authors:  Grant Colfax; Glenn-Milo Santos; Priscilla Chu; Eric Vittinghoff; Andreas Pluddemann; Suresh Kumar; Carl Hart
Journal:  Lancet       Date:  2010-08-07       Impact factor: 79.321

Review 7.  The rise of methamphetamine in Southeast and East Asia.

Authors:  Rebecca McKetin; Nicholas Kozel; Jeremy Douglas; Robert Ali; Balasingam Vicknasingam; Johannes Lund; Jih-Heng Li
Journal:  Drug Alcohol Rev       Date:  2008-05

Review 8.  Impact of HIV prevention programs on drug users in Malaysia.

Authors:  Adeeba Kamarulzaman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11       Impact factor: 3.731

  8 in total
  13 in total

1.  Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia.

Authors:  Farrah Khan; Archana Krishnan; Mansur A Ghani; Jeffrey A Wickersham; Jeannia J Fu; Sin How Lim; Sangeeth Kaur Dhaliwal; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Subst Use Misuse       Date:  2017-02-22       Impact factor: 2.164

2.  Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Authors:  Aishwarya Vijay; Alexander R Bazazi; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2015-02-18

3.  Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.

Authors:  Alexander R Bazazi; Jeffrey A Wickersham; Martin P Wegman; Gabriel J Culbert; Veena Pillai; Roman Shrestha; Haider Al-Darraji; Michael M Copenhaver; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2017-05-04       Impact factor: 2.226

4.  Early Initiation of Amphetamine-Type Stimulants (ATS) Use Associated with Lowered Cognitive Performance among Individuals with Co-Occurring Opioid and ATS Use Disorders in Malaysia.

Authors:  Weng-Tink Chooi; Norzarina Mohd Zaharim; Alethea Desrosiers; Imran Ahmad; Mohd Azhar Mohd Yasin; Sharifah Z Syed Jaapar; Richard S Schottenfeld; Balasingam K Vicknasingam; Marek C Chawarski
Journal:  J Psychoactive Drugs       Date:  2017-06-29

5.  The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: Important targets for intervention.

Authors:  Kelsey B Loeliger; Ruthanne Marcus; Jeffrey A Wickersham; Veena Pillai; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Addict Behav       Date:  2015-09-25       Impact factor: 3.913

Review 6.  The globalization of addiction research: capacity-building mechanisms and selected examples.

Authors:  Richard A Rawson; George Woody; Thomas F Kresina; Steven Gust
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

7.  Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.

Authors:  Richard S Schottenfeld; Marek C Chawarski; Mehmet Sofuoglu; Weng-Tink Chooi; Norzarina M Zaharim; M Azhar M Yasin; Imran Ahmad; Sharifah Zubaidiah Syed Jaapar; B Kasinather Vicknasingam
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

8.  Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.

Authors:  Trena I Mukherjee; Veena Pillai; Siti Hafizah Ali; Frederick L Altice; Adeeba Kamarulzaman; Jeffrey A Wickersham
Journal:  Int J Drug Policy       Date:  2017-06-23

9.  Depression in chronic ketamine users: Sex differences and neural bases.

Authors:  Chiang-Shan R Li; Sheng Zhang; Chia-Chun Hung; Chun-Ming Chen; Jeng-Ren Duann; Ching-Po Lin; Tony Szu-Hsien Lee
Journal:  Psychiatry Res Neuroimaging       Date:  2017-09-05       Impact factor: 2.376

10.  Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study.

Authors:  Jeffrey A Wickersham; Britton A Gibson; Alexander R Bazazi; Veena Pillai; Courtney J Pedersen; Jaimie P Meyer; Nabila El-Bassel; Kenneth H Mayer; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Sex Transm Dis       Date:  2017-11       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.